Leblanc Y, Roy P, Boyce S, Brideau C, Chan C C, Charleson S, Gordon R, Grimm E, Guay J, Léger S, Li C S, Riendeau D, Visco D, Wang Z, Webb J, Xu L J, Prasit P
Merck Frosst Centre for Therapeutic Research, Québec, Canada.
Bioorg Med Chem Lett. 1999 Aug 2;9(15):2207-12. doi: 10.1016/s0960-894x(99)00365-0.
Extensive SAR has been established in the alkoxy lactone series and this has lead to the discovery of DFP (5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanon e), a potent COX-2 inhibitor exhibiting in vivo efficacy in all models studied.
在烷氧基内酯系列中已建立了广泛的构效关系(SAR),这导致了DFP(5,5 - 二甲基 - 3 -(2 - 丙氧基)- 4 - 甲磺酰基苯基)- 2(5H)- 呋喃酮)的发现,它是一种强效的COX - 2抑制剂,在所研究的所有模型中均表现出体内疗效。